Argo Biopharmaceutical Co., Ltd. (Argo Biopharma), a clinical-stage biotechnology company committed to developing ...
Familial Hypobetalipoproteinemia (FHBL), caused by variants in the apolipoprotein B (APOB) gene, is a rare autosomal co-dominant monogenic disorder characterized by lifelong low plasma levels of total ...
Lucknow: Hepatic venous pressure gradient (HVPG), special medical test to gauge pressure inside liver, was performed for the ...
Asianet Newsable on MSN
BHC stock plummets on failed liver cirrhosis trial: Retail says 'lost battle but not the war'
The failed clinical program evaluated rifaximin SSD for the delay of the first episode of hepatic encephalopathy (HE) in ...
Bausch Health Companies Inc. was hit by a failed RED-C Phase 3, weak cash flow vs. interest, and a risky pipeline. Click for ...
A potential inflection point that Bausch Health hoped could diversify its portfolio has vanished with a pair of phase 3 failures for a new formulation of the company’s bread-and-butter Xifaxan—a ...
Bausch Health said on Friday its experimental treatment failed to prevent the first clinically visible symptoms of a neurological condition in patients with a type of liver disease, missing the main ...
Hepatic steatosis is a core pathological feature of metabolic dysfunction-associated steatotic liver disease (MASLD). It not ...
Steatotic liver disease (commonly called fatty liver disease) progresses silently. Even in the absence of noticeable symptoms ...
ATTR program on hold amid safety risks; HAE therapy faces tough rivals and small market. Read more analysis here.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results